[Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
Iakovlev
S V
SV
Polushkina
N R
NR
Iakovlev
V P
VP
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001372:Aza Compounds; D002986:Clinical Trials as Topic; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000378:metabolism / Q000382:microbiology; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000378:metabolism / Q000382:microbiology; D006801:Humans; D000077266:Moxifloxacin; D011804:Quinolines; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000378:metabolism / Q000382:microbiology
D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin